Bandaram Pharma Packtech Ltd

A sharp decline has dragged Bandaram Pharma Packtech Ltd to a fresh 52-week low of Rs 19.8 on 3 Aug 2026, marking a 44.12% drop over the past year and signalling sustained pressure on this healthcare services micro-cap despite broader market gains.

For the second consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 19.99 on 28 Jul 2026. This latest drop extends the stock’s year-long slide, which now stands at a steep 47.37% loss, significantly underperforming the broader Sensex’s modest 4.89% decline over the same period.

A sharp decline of 14.89% intraday dragged Bandaram Pharma Packtech Ltd to a fresh 52-week low of Rs 20 on 27 Jul 2026, marking a significant 44.5% drop over the past year. This comes despite the broader market's positive momentum, with the Sensex trading 0.84% higher, highlighting a stark divergence in performance.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Bandaram Pharma Packtech Ltd’s stock price has declined to a fresh 52-week low of ₹22 on 03 Jul 2026, marking a significant milestone in its ongoing downward trajectory. The stock closed just 4.35% above this low, reflecting persistent pressure amid broader sector and market dynamics.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Bandaram Pharma Packtech Ltd. (BSE: 524602), a micro-cap healthcare services company with a market capitalisation of ₹52.00 crores, reported a dramatic revenue acceleration in Q4 FY26 that failed to translate into meaningful bottom-line growth. The company posted a consolidated net profit of ₹0.09 crores for the quarter ended March 2026, representing a sharp 52.63% decline quarter-on-quarter and a 40.00% drop year-on-year, even as net sales surged 76.95% sequentially to ₹26.26 crores. Following the results, the stock traded at ₹28.45 on June 1, 2026, reflecting a 5.33% single-day gain but remaining 42.76% below its 52-week high of ₹49.70.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook.

For the fourth consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 22 on 1 Apr 2026. This marks a steep 20.03% drop over the last four days, underscoring persistent selling pressure despite a broadly positive market backdrop.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.